Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Foresite Capital Management
Biotech
Troubled Theseus mulls bids from both OrbiMed and Concentra
It’s been a wild November for Theseus. Just a couple of weeks ago, the biotech laid off staff. Days later, the company received two buyout offers.
James Waldron
Nov 27, 2023 9:31am
Kinnate buys OrbiMed's stake in cancer JV to go solo in China
Feb 22, 2023 9:30am
Foresite Labs nabs $173M fund for data-fueled biotechs
Mar 3, 2022 12:00pm
Novartis-backed ImmPACT Bio gets $111M, ex-Pfizer exec for CEO
Jan 20, 2022 5:00am
Mystery revealed: Mythic lands $103M to take on ADC class
Dec 16, 2021 10:30am
Gary Glick's Odyssey begins with $218M for 7 assets
Dec 7, 2021 7:00am
